No abstract available
MeSH terms
-
Antibodies, Monoclonal, Humanized / administration & dosage
-
Antibodies, Monoclonal, Murine-Derived / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Bleomycin / administration & dosage
-
Breast Neoplasms / diagnosis
-
Breast Neoplasms / drug therapy*
-
Cyclophosphamide / administration & dosage
-
Dacarbazine / administration & dosage
-
Doxorubicin / administration & dosage
-
Female
-
Fertility Preservation
-
Humans
-
Lapatinib
-
Lymphoma / complications
-
Lymphoma / diagnosis
-
Lymphoma / drug therapy*
-
Molecular Targeted Therapy
-
Prednisone / administration & dosage
-
Pregnancy
-
Pregnancy Complications, Neoplastic / diagnosis
-
Pregnancy Complications, Neoplastic / drug therapy*
-
Pregnancy Outcome
-
Quinazolines / administration & dosage
-
Receptor, ErbB-2 / antagonists & inhibitors
-
Rituximab
-
Trastuzumab
-
Vinblastine / administration & dosage
-
Vincristine / administration & dosage
Substances
-
Antibodies, Monoclonal, Humanized
-
Antibodies, Monoclonal, Murine-Derived
-
Quinazolines
-
Lapatinib
-
Bleomycin
-
Rituximab
-
Vincristine
-
Vinblastine
-
Dacarbazine
-
Doxorubicin
-
Cyclophosphamide
-
Receptor, ErbB-2
-
pertuzumab
-
Trastuzumab
-
Prednisone
Supplementary concepts
-
ABVD protocol
-
CHOP protocol